Association of dehydromonocrotaline with rat red blood cells

Chemical Research in Toxicology

Volumn 10, Issue 6, 1997, Pages 694-701

  Lamé, Michael W ^a   Jones, A Daniel ^a   Morin, Dexter ^a   Wilson, Dennis W ^a   Segall, H J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; HEME; MONOCROTALINE; MONOCROTALINE PYRROLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ERYTHROCYTE GHOST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; METABOLIC ACTIVATION; NONHUMAN; PULMONARY HYPERTENSION; RAT; THIN LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE;

ANIMALS; BIOLOGICAL TRANSPORT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; GLOBINS; HEME; INJECTIONS, INTRAVENOUS; MALE; MEMBRANES; MONOCROTALINE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0030903623     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960173v     Document Type: Article

References (37)

1. Smith, L. W., Culvenor, C. C. J. (1981) Plant sources of hepatotoxic pyrrolizidine alkaloids. J. Nat. Prod. 44, 129-152.
2. Meyrick, B., Gamble, W., and Reid, L. (1980) Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 239, H692-H702.
3. Huxtable, R., Ciaramitaro, D., and Eisenstein, D. (1978) The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, denydroretronecine, on the biochemical function of the pulmonary endothelium. Mol. Pharmacol. 14, 1189-1203.
4. Wilson, D. W., Segall, H. J., Pan, L. C. W., and Dunston, S. K. (1989) Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats. Microvasc. Res. 38, 57-80.
5. Pan, L. C., Wilson, D. W., Lamé, M. W., Jones, A. D. and Segall, H. J. (1993) COR Pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. Toxicol. Appl. Pharmacol. 118, 87-97.
6. Mattocks, A. R. (1968) Toxicity of pyrrolizidine alkaloids. Nature 217, 723-728.
7. Reindel, J. F., Ganey, P. E., Wagner, J. G., Slocombe, R. F., and Roth, R. A. (1990) Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 106, 179-200.
8. Bruner, L. H., Carpenter, L. J., Hamlow, P., and Roth, R. A. (1986) Effect of mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Toxicol. Appl. Pharmacol. 85, 416-427.
9. 14C]Monocrotaline kinetics and metabolism in the rat. Drug Metab. Dispos. 19, 135-139.
10. Pan, L. C., Lamé, M. W., Morin, D., Wilson, D. W., and Segall, H. J. (1991) Red blood cells augment transport of reactive metabolites of monocrotaline from the liver to lung in isolated and tandem liver and lung preparations. Toxicol. Appl. Pharmacol. 110, 336-346.
11. Lamé, M. W., Morin, D., Wilson, D. W., and Segall, H. J. (1996) Methods to obtain radiolabelled monocrotaline. J. Labelled Compd. Radiopharm. 38, 1053-1060.
12. 3H]isoretronecanol and their incorporation into the retronecine moiety of riddelliine in Senecio riddellii. J. Nat. Prod. 49, 838-844.
13. Adams, R., and Rogers, E. F. (1939) The structure of monocrotaline, the alkaloid in Crotalaria spectabilis and Crotalaria retusa. I. J. Am. Chem. Soc. 61, 2815-2819.
14. Hoskins, M. W., and Crout, D. H. G. (1977) Pyrrolizidine alkaloids analogues. Preparation of semisynthetic esters of retronecine. J. Chem. Soc., Perkin Trans. I 538-544.
15. Robins, D. J. (1989) Biosynthesis of pyrrolizidine alkaloids. Chem. Soc. Rev. 18, 375-408.
16. Lamé, M. W., Morin, D., Jones, A. D., Segall, H. J., and Wilson, D. W. (1990) Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicol. Lett. 51, 321-329.
17. Mattocks, A. R., Jukes, R., and Brown, J. (1989) Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 27, 561-567.
18. Culvenor, C. C. J., Edgar, J. A., Smith, L. W., and Tweeddale, H. J. (1970) Dihydropyrrolizines: III. Preparation and reactions of derivatives related to pyrrolizidine alkaloids. Aust. J. Chem. 23, 1853-1867.
19. Mattocks, A. R., and Jukes, R. (1990) Recovery of the pyrrolic nucleus of pyrrolizidine alkaloid metabolites from sulphur conjugates in tissues and body fluids. Chem.-Biol. Interact. 75, 225-239.
20. Sun, J. D., and Dent, J. G. (1980) A new method for measuring covalent binding of chemicals to cellular macromolecules. Chem.-Biol. Interact. 32, 41-61.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
22. Dodge, J. T., Mitchell, C., and Hanahan, D. J. (1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100, 119-130.
23. Mattocks, A. R. (1969) Dihydropyrrolizine derivatives from unsaturated pyrrolizidine alkaloids. J. Chem. Soc. C 1155-1162.
24. Ferranti, P., Carbone, V., Sannolo, N., Fiume, I., and Malorni, A. (1993) Mass spectrometric analysis of rat hemoglobin by FAB-overlapping: Primary structure of the α-major and of four β-constitutive chains. Int. J. Biochem. 25, 1943-1950.
25. 14C]monocrotaline by isolated perfused rat liver. Drug Metab. Dispos. 19, 516-524.
26. 14C]-monocrotaline in the rat. Drug Metab. Dispos. 23, 422-429.
27. Mattocks, A. R., and Bird, I. (1983) Alkylation by dehydroretronecine, a cytotoxic metabolite of some pyrrolizidine alkaloids: An in vitro test. Toxicol. Lett. 16, 1-8.
28. Tomer, K. B., Gross, M. L., and Deinzer, M. L. (1986) Fast atom bombardment and tandem mass spectrometry of covalently modified nucleosides and nucleotides: Adducts of pyrrolizidine alkaloid metabolites. Anal. Chem. 58, 2527-2534.
29. Wickramanayake, P. P., Arbogast, B. L., Buhler, D. R., Deinzer, M. L., and Burlingame, A. L. (1985) Alkylation of nucleosides and nucleotides by dehydroretronecine; charactenzation of covalent adducts by liquid secondary ion mass spectrometry. J. Am. Chem. Soc. 107, 2485-2488.
30. Reed, R. L., Ahern, K. G., Pearson, G. D., and Buhler, D. R. (1988) Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids. Carcinogenesis 9, 1355-1361.
31. Hutchins, D. A., Skipper, P. L., Naylor, S., and Tannenbaum, S. R. (1988) Isolation and characterization of the major fluoranthene-hemoglobin adducts formed in vivo in the rat. Cancer Res. 48, 4756-4761.
32. Green, L. C., Skipper, P. L., Turesky, R. J., Bryant, M. S., and Tannenbaum, S. R. (1984) In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Res. 44, 4254-4259.
33. Bryant, M. S., Skipper, P. L., Tannenbaum, S. R., and Maclure, M. (1987) Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 47, 602-608.
34. Peterson, L. A., Carmella, S. G., and Hecht, S. S (1990) Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 11, 1329-1333.
35. Bruenner, B. A., Jones, A. D., and German, J. B. (1995) Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. Chem. Res. Toxicol. 8, 552-559.
36. Kaur S., Hollander, D., Haas, R., and Burlingame, A. L. (1989) Characterization of structural xenobiotic modifications in proteins by high sensitivity tandem mass spectrometry: Human hemoglobin treated in vitro with styrene 7,8-oxide. J. Biol. Chem. 264, 16981-16984.
37. Naylor S., Gan, L.-S., Day, B. W., Pastorelli, R., Skipper, P. L., and Tannenbaum, S. R. (1990) Benzo[α]pyrenediol epoxide adduct formation in mouse and human hemoglobin: Physicochemical basis of dosimetry. Chem. Res. Toxicol. 3, 111-117.